Form 4: Ionis Pharmaceuticals Officer C. Frank Bennett Reports Stock Purchase

C. Frank Bennett, an officer of Ionis Pharmaceuticals, reports purchasing 383 shares of common stock through the company's employee stock purchase plan on February 29, 2024.

Summary

• On February 29, 2024, C. Frank Bennett, an officer of Ionis Pharmaceuticals, acquired 383 shares of common stock.
• The purchase was made through the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan.
• The price per share was $34.425.
• Following the transaction, Bennett directly owns 79,462 shares of Ionis Pharmaceuticals common stock.
• These shares may not be sold until August 31, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The stock purchase could be seen as slightly positive, but it's a routine transaction.

Positives

• The purchase of shares by a company officer could be interpreted as a sign of confidence in the company's future prospects.

Future Outlook

There is no future outlook provided in the document.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders trade in their own company's stock. It provides transparency to the market regarding the actions of company officers.

Stakeholder Impact

• The stock purchase by an officer may have a minor positive impact on shareholder sentiment.

Key Dates